ALYSON HOOVER: Open Payments
NPI 1548601032 · CARLISLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 15 payments from 8 companies in 2025. Trend: 2023 $888 · 2024 $125 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $108 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Amgen Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, SHINGRIX, EVENITY, UBRELVY, AIRSUPRA, ENROUTE Transcarotid Neuroprotection System, AUSTEDO XR, CONTRAVE.
Industry payments across PA — which companies pay providers there.
